We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

93 hedge funds and large institutions have $193M invested in Rigel Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 24 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

126% more capital invested

Capital invested by funds: $85.4M → $193M (+$107M)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

29% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 24

17% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 18

8.47% more ownership

Funds ownership: 59.18% → 67.65% (+8.5%)

2% more funds holding

Funds holding: 91 → 93 (+2)

61% less call options, than puts

Call options by funds: $2.83M | Put options by funds: $7.22M

Holders
93
Holders Change
+2
Holders Change %
+2.2%
% of All Funds
1.34%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
21
Increased
31
Reduced
24
Closed
18
Calls
$2.83M
Puts
$7.22M
Net Calls
-$4.39M
Net Calls Change
-$4.99M

Top Buyers

1
Invesco
Invesco
Georgia
+$12.1M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$5.19M
3
CM
CM Management
Florida
+$3.41M
4
VOYA Investment Management
VOYA Investment Management
Georgia
+$1.44M
5
N
Nuveen
North Carolina
+$1.35M

Top Sellers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.51M
2
SCM
Soleus Capital Management
Connecticut
-$1.28M
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$1.12M
4
AC
Armistice Capital
New York
-$1.03M
5
Jane Street
Jane Street
New York
-$944K
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
51
Russell Investments Group
United Kingdom
$171K +$1.46K +124 +1%
OQS
52
Occudo Quantitative Strategies
Florida
$168K +$122K +10,389 New
MIM
53
MetLife Investment Management
New Jersey
$166K -$12 -1 -0%
Mirae Asset Global ETFs Holdings
54
Mirae Asset Global ETFs Holdings
Hong Kong
$156K +$11.8K +1,001 +12%
CF
55
Corebridge Financial
Texas
$151K -$682 -58 -0.6%
GC
56
Globeflex Capital
California
$149K +$108K +9,200 New
UBS Group
57
UBS Group
Switzerland
$148K +$108K +9,176 New
Deutsche Bank
58
Deutsche Bank
Germany
$111K +$1.09K +93 +1%
SG Americas Securities
59
SG Americas Securities
New York
$107K -$109K -9,297 -58%
Wells Fargo
60
Wells Fargo
California
$96.4K -$1.01K -86 -1%
Public Employees Retirement Association of Colorado
61
Public Employees Retirement Association of Colorado
Colorado
$62K -$12 -1 -0%
New York State Common Retirement Fund
62
New York State Common Retirement Fund
New York
$54K -$12 -1 -0%
US Bancorp
63
US Bancorp
Minnesota
$52.4K – – –
CFM
64
Catalyst Funds Management
Australia
$43.7K +$31.7K +2,700 New
Legal & General Group
65
Legal & General Group
United Kingdom
$28.3K – – –
Royal Bank of Canada
66
Royal Bank of Canada
Ontario, Canada
$28K -$47.2K -4,013 -70%
AIP
67
Ameritas Investment Partners
Nebraska
$24K – – –
PMAM
68
Picton Mahoney Asset Management
Ontario, Canada
$21K +$9.62K +818 +181%
California State Teachers Retirement System (CalSTRS)
69
California State Teachers Retirement System (CalSTRS)
California
$20.4K – – –
TRCT
70
Tower Research Capital (TRC)
New York
$13.3K -$167K -14,236 -95%
FFA
71
Farther Finance Advisors
California
$10.8K +$7.84K +667 New
AB
72
Amalgamated Bank
New York
$10K – – –
Osaic Holdings
73
Osaic Holdings
Arizona
$8.09K +$4K +340 +213%
National Bank of Canada
74
National Bank of Canada
Quebec, Canada
$6.47K – – –
Northwestern Mutual Wealth Management
75
Northwestern Mutual Wealth Management
Wisconsin
$4.13K – – –
1 2
3
4 5

RIGL Hedge Fund Activity: Q3 2024 in Review

93 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q3 2024, worth a combined $193M — up 126% from $85.4M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new RIGL positions and 18 closed out — a net gain of 3 holders — while 31 added to existing stakes and 24 trimmed.

The largest buyer was Invesco, adding an estimated $12.1M. The largest seller was Acadian Asset Management, cutting an estimated $1.51M.

  • 93 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q3 2024, up from 91 in Q2 2024.
  • Funds reported $193M of Rigel Pharmaceuticals stock for Q3 2024, up 126% quarter-over-quarter.
  • 21 funds opened new Rigel Pharmaceuticals positions in Q3 2024 and 18 closed out, a net change of +3 holders.
  • The largest Rigel Pharmaceuticals buyer in Q3 2024 was Invesco, an estimated $12.1M added.
  • The largest Rigel Pharmaceuticals seller in Q3 2024 was Acadian Asset Management, an estimated $1.51M sold.

Based on aggregated 13F filings for Q3 2024.